Tagged with Kite

China China: Fosun Pharma in Profile

China At a time when the country’s economy has fallen into a slump with the currency sinking to its lowest level in 16 years, Chinese giant Fosun Pharma continues to agressively advance its activities in everything from pharmaceuticals to medical devices and diagnosis to healthcare services. Through its multiple subsidiaries, as…

China Enters CAR-T Era with Fosun-Kite Yescarta Approval

China China Enters CAR-T Era with Fosun-Kite Yescarta Approval

China A historic approval for Fosun-Kite’s CAR-T therapy Yescarta in China looks set to pave the way for further developments in the Chinese cell and gene therapy space, as multinationals look to bring their new therapies to the rapidly expanding China market Yescarta, originally approved in the US in 2017…

China Pharma News: First CAR-T Approval; AZ & Bayer Take VBP Hit; Lonza Boosts Manufacturing Capacity

China China Pharma News: First CAR-T Approval; AZ & Bayer Take VBP Hit; Lonza Boosts Manufacturing Capacity

China The latest news from Chinese pharma, including a historic first approval for Fosun Kite’s CAR-T therapy Yescarta; the Big Pharma losers from the latest round of price cuts for off-patent drugs; Lonza’s new investment in Chinese API manufacturing expansion; and Dingdang Health’s recent USD 220 million financing round. Yescarta…

Four Cell & Gene Companies to Know in China

China Four Cell & Gene Companies to Know in China

China While cell and gene therapies are all the rage now, a little known fact is that the world’s first approved gene therapy actually came from a Chinese company – in 2003! Gendicine® was a gene therapy for the treatment of haemophilia B. While China mostly lost the advantage of that…

Interview: Markwin Velders – Vice President Operations Europe, Kite Pharma, The Netherlands

pharma Interview: Markwin Velders – Vice President Operations Europe, Kite Pharma, The Netherlands

pharma The Netherlands provides a flourishing environment for biotech to grow. The vice president for European operations at Kite Pharma discusses how biotech start-ups can find their path to success and how Kite Pharma is looking at new innovative therapies for cancer treatment. Before joining T-Cell Factory, later acquired by Kite…

pharma Interview: Muzaffer Bal –  General Manager, Ali Raif Ilaç Sanayi (ARİS), Turkey

pharma The general manager of Ali Raif, Muzaffer Bal illustrates the various success factors that allowed the company to secure market leading positions within Turkey and across Europe, while also highlighting how the company has adapted its portfolio to shifting market dynamics. Muzaffer, as an introduction for our readers, please provide…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page